W
e read with interest the work of González et al. (1) , which to our knowledge is the largest study of the predictive value of thyroid antibody testing for future thyroid dysfunction in patients with type 1 diabetes. We previously examined this in a retrospective study of 467 patients with diabetes (81 with type 1 diabetes) and found that, although the presence of thyroid autoantibodies at diagnosis predicted later thyroid dysfunction, a high-normal baseline thyroid stimulating hormone (TSH) level (i.e., above the 75th percentile) was more predictive (2) . When both were combined in the same statistical model, only the baseline TSH level remained a statistically significant predictor. We speculated that this was because a high-normal TSH represents early thyroid disease and that the TSH assay may have been more sensitive than the antibody assays.
It would be interesting to know whether a similar pattern was seen in the data of González et al.
